Today you’ll learn about how a cure for peanut allergies could be on the way to being a reality, how scientists are looking into treatments for an unreachable itch, and how a new study reports that talking about your financial debt makes you more likely to pay it off.
Peanut Allergy Blocker
- “Researchers Block Allergic Reactions to Peanuts in Mice” by Sarah Wheelan
- “Peanut allergen inhibition prevents anaphylaxis in a humanized mouse model” by NADA S. ALAKHRAS et al.
- “When peanuts are poison” by Julie McDowell
- “Racial and Ethnic Data Reported for Peanut Allergy Epidemiology Do Little to Advance Its Cause, Treatment, or Prevention” by Nigel Mark Thomas
Unreachable Itch
- “Drug Shows Promise Against “Unreachable Itch” Condition” by Molly Campbell
- “Phase 2 Trial of Difelikefalin in Notalgia Paresthetica” by Brian S. Kim et al.
- “New Formulation of FDA-Approved Drug Shows Encouraging Results for Treating a Common Itch Condition” by Mount Sinai
- “Oral Drug Shows Benefit for Notalgia Paresthetica in Mid-Stage Trial” by Elizabeth Short
Debt Fear
- “Fear of judgment is keeping consumers indebted – study shows peer groups can help turn that around” by UNIVERSITY OF WESTERN ONTARIO, IVEY BUSINESS SCHOOL
- “EXPRESS: Helping Those That Hide: Anticipated Stigmatization Drives Concealment and a Destructive Cycle of Debt” by Michael Moorhouse et al.
Follow Curiosity Daily on your favorite podcast app to get smarter withCalli andNate — for free! Still curious? Get exclusive science shows, nature documentaries, and more real-life entertainment on discovery+! Go to https://discoveryplus.com/curiosity to start your 7-day free trial. discovery+ is currently only available for US subscribers.
Find episode transcripts here: https://curiosity-daily-4e53644e.simplecast.com/episodes/peanut-allergy-blocker-unreachable-itch-debt-fear
The podcast Curiosity Daily is embedded on this page from an open RSS feed. All files, descriptions, artwork and other metadata from the RSS-feed is the property of the podcast owner and not affiliated with or validated by Podplay.